Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog) Trial Phase 2 Completed Aug. 22, 2018
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004 Trial Phase 3 Unknown Aug. 13, 2018
Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease Trial N/A Terminated Aug. 13, 2018
Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528 Trial Phase 3 Completed Aug. 12, 2018
Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients Trial Phase 1 Withdrawn Aug. 9, 2018
Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes Trial Phase 2 Completed Aug. 7, 2018
A Comparison of Voice Amplifiers and Personal Communication Systems in Individuals With Parkinson's Disease Trial N/A Unknown Aug. 6, 2018
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa Trial Phase 3 Completed Aug. 5, 2018
Effects of Feet Mechanical Stimulation on Cardiovascular Autonomic Profile and Inflammation in Parkinson's Disease Trial N/A Completed Aug. 2, 2018
Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan⢠Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET) Trial N/A Completed Aug. 1, 2018
Accuracy of Markerless Motion Capture Evaluation in Parkinson's Disease After DBS Trial N/A Completed July 30, 2018
Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion Trial N/A Unknown July 26, 2018
Protocol: Mental Practice Combined With Physical Practice of Gait in Parkinson's Disease. Trial N/A Unknown July 26, 2018
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Trial Phase 3 Completed July 25, 2018